Tapdi Oksijen Ozelglik ve Egitim Hizlmetlerinayi Ticaret AS (IST:TNZTP) ROE %: 3.45% (As of Mar. 2026) — 85% Below Median


IST:TNZTP Tapdi Oksijen Ozel Saglik ve Egitim Hizlmetleri Sanayi Ticaret AS IST:TNZTP
93 GF Score
Price ₺26.06
GF Value ₺29.23
Valuation Modestly Undervalued
! 2 Warning Signs
View Full Analysis

What is Tapdi Oksijen Ozelglik ve Egitim Hizlmetlerinayi Ticaret AS ROE %?

Tapdi Oksijen Ozelglik ve Egitim Hizlmetlerinayi Ticaret AS IST:TNZTP +0.54% 93 ROE % is 3.45% as of Mar. 2026, which is 85% below its 10-year median of 22.54. GuruFocus rates IST:TNZTP with a GF Score™ of 93/100 and a GF Value™ of ₺29.23 (Modestly Undervalued). The stock has 2 warning signs investors should review. Among 628 Healthcare Providers & Services companies, Tapdi Oksijen Ozelglik ve Egitim Hizlmetlerinayi Ticaret AS ranks better than 60.67% on this metric.

ROE % is calculated as Net Income divided by its average Total Stockholders Equity over a certain period of time. Tapdi Oksijen Ozelglik ve Egitim Hizlmetlerinayi Ticaret AS's annualized net income for the quarter that ended in Mar. 2026 was ₺291 Mil. Tapdi Oksijen Ozelglik ve Egitim Hizlmetlerinayi Ticaret AS's average Total Stockholders Equity over the quarter that ended in Mar. 2026 was ₺8,446 Mil. Therefore, Tapdi Oksijen Ozelglik ve Egitim Hizlmetlerinayi Ticaret AS's annualized ROE % for the quarter that ended in Mar. 2026 was 3.45%.

The historical rank and industry rank for Tapdi Oksijen Ozelglik ve Egitim Hizlmetlerinayi Ticaret AS's ROE % or its related term are showing as below:

IST:TNZTP' s ROE % Range Over the Past 10 Years
Min: 9.05   Med: 22.54   Max: 37.88
Current: 9.05

During the past 7 years, Tapdi Oksijen Ozelglik ve Egitim Hizlmetlerinayi Ticaret AS's highest ROE % was 37.88%. The lowest was 9.05%. And the median was 22.54%.

IST:TNZTP's ROE % is ranked better than
60.67% of 628 companies
in the Healthcare Providers & Services industry
Industry Median: 5.72 vs IST:TNZTP: 9.05

Tapdi Oksijen Ozelglik ve Egitim Hizlmetlerinayi Ticaret AS  (IST:TNZTP) ROE % Explanation

ROE % measures the rate of return on the ownership interest (shareholder's equity) of the common stock owners. It measures a firm's efficiency at generating profits from every unit of shareholders' equity (also known as net assets or assets minus liabilities). ROE % shows how well a company uses investment funds to generate earnings growth. ROE %s between 15% and 20% are considered desirable.

The factors that affect a company's ROE % can be illustrated with the three-step DuPont Analysis:

ROE %(Q: Mar. 2026 )
=Net Income/Total Stockholders Equity
=291.304/8446.237
=(Net Income / Revenue )*(Revenue / Total Assets)*(Total Assets / Total Stockholders Equity)
=(291.304 / 3877.344)*(3877.344 / 10359.3755)*(10359.3755 / 8446.237)
=Net Margin %*Asset Turnover*Equity Multiplier
=7.51 %*0.3743*1.2265
=ROA %*Equity Multiplier
=2.81 %*1.2265
=3.45 %

With this breakdown, it is clear that if a company grows its Net Profit Margin, its Asset Turnover, or its Leverage, it can grow its ROE %.

The factors that affect a company's ROE % can also be illustrated with the five-step DuPont Analysis:

ROE %(Q: Mar. 2026 )
=Net Income/Total Stockholders Equity
=291.304/8446.237
=(Net Income / Pre-Tax Income) * (Pre-Tax Income / Operating Income) * (Operating Income / Revenue) * (Revenue / Total Assets) * (Total Assets / Total Stockholders Equity)
= (291.304 / 1370.688) * (1370.688 / 1072.924) * (1072.924 / 3877.344) * (3877.344 / 10359.3755) * (10359.3755 / 8446.237)
= Tax Burden * Interest Burden * Operating Margin % * Asset Turnover * Equity Multiplier
= 0.2125 * 1.2775 * 27.67 % * 0.3743 * 1.2265
=3.45 %

Note: The net income data used here is four times the quarterly (Mar. 2026) net income data. The Revenue data used here is four times the quarterly (Mar. 2026) revenue data. The same rule applies to Pre-Tax Income and Operating Income.
* In the five-step DuPont Analysis, Operating Income is only available for non-financial companies. Thus, for Insurance companies, we use EBIT as a substitution of Operating Income. For Banks, both Operating Income and EBIT is unavailable. Thus we combined Interest Burden and Operating Margin % into Pretax Margin %, and the DuPont Analysis is divided into four components instead.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Be Aware

Net Income is used.

Because a company can increase its ROE % by having more financial leverage, it is important to watch the equity multiplier when investing in high ROE % companies. Like ROA %, ROE % is calculated with only 12 months data. Fluctuations in company's earnings or business cycles can affect the ratio drastically. It is important to look at the ratio from a long term perspective.

Asset light businesses require very few assets to generate very high earnings. Their ROE %s can be extremely high.


Tapdi Oksijen Ozelglik ve Egitim Hizlmetlerinayi Ticaret AS ROE % Related Terms


Tapdi Oksijen Ozelglik ve Egitim Hizlmetlerinayi Ticaret AS ROE % Historical Data

* Premium members only.

The historical data trend for Tapdi Oksijen Ozelglik ve Egitim Hizlmetlerinayi Ticaret AS's ROE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Tapdi Oksijen Ozelglik ve Egitim Hizlmetlerinayi Ticaret AS ROE % Chart

Tapdi Oksijen Ozelglik ve Egitim Hizlmetlerinayi Ticaret AS Annual Data
Trend Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
ROE %
Get a 7-Day Free Trial 11.46 22.54 37.88 28.30 9.17

Tapdi Oksijen Ozelglik ve Egitim Hizlmetlerinayi Ticaret AS Quarterly Data
Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
ROE % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 5.33 15.42 4.33 14.27 3.45

IST:TNZTP vs HCA, THC, DVA: ROE % Comparison

For the Medical Care Facilities subindustry, Tapdi Oksijen Ozelglik ve Egitim Hizlmetlerinayi Ticaret AS's ROE %, along with its competitors' market caps and ROE % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Tapdi Oksijen Ozelglik ve Egitim Hizlmetlerinayi Ticaret AS ROE % vs Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, Tapdi Oksijen Ozelglik ve Egitim Hizlmetlerinayi Ticaret AS's ROE % distribution charts can be found below:

* The bar in red indicates where Tapdi Oksijen Ozelglik ve Egitim Hizlmetlerinayi Ticaret AS's ROE % falls into.


IST:TNZTP
93GF Score
Tapdi Oksijen Ozel Saglik ve Egitim Hizlmetleri Sanayi Ticaret AS IST:TNZTP
ROE % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Tapdi Oksijen Ozelglik ve Egitim Hizlmetlerinayi Ticaret AS ROE % Calculation

Tapdi Oksijen Ozelglik ve Egitim Hizlmetlerinayi Ticaret AS's annualized ROE % for the fiscal year that ended in Dec. 2025 is calculated as

ROE %=Net Income (A: Dec. 2025 )/( (Total Stockholders Equity (A: Dec. 2024 )+Total Stockholders Equity (A: Dec. 2025 ))/ count )
=695.678/( (7168.823+8007.932)/ 2 )
=695.678/7588.3775
=9.17 %

Tapdi Oksijen Ozelglik ve Egitim Hizlmetlerinayi Ticaret AS's annualized ROE % for the quarter that ended in Mar. 2026 is calculated as

ROE %=Net Income (Q: Mar. 2026 )/( (Total Stockholders Equity (Q: Dec. 2025 )+Total Stockholders Equity (Q: Mar. 2026 ))/ count )
=291.304/( (8007.932+8884.542)/ 2 )
=291.304/8446.237
=3.45 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

In the calculation of annual ROE %, the net income of the last fiscal year and the average total shareholder equity over the fiscal year are used. In calculating the quarterly data, the net income data used here is four times the quarterly (Mar. 2026) net income data. ROE % is displayed in the 30-year financial page.

Frequently Asked Questions Learn more about ROE % →
What does a ROE % of 3.45% mean?
Tapdi Oksijen Ozelglik ve Egitim Hizlmetlerinayi Ticaret AS (IST:TNZTP) has a ROE % of 3.45% as of Mar. 2026. Return on equity is the ratio of current-period net income to average two-period total equity. View historical data on Tapdi Oksijen Ozelglik ve Egitim Hizlmetlerinayi Ticaret AS and its competitors. This is 85% below median its historical median of 22.54. Over the past decade, Tapdi Oksijen Ozelglik ve Egitim Hizlmetlerinayi Ticaret AS's ROE % has ranged from 9.05 to 37.88. According to the industry distribution chart, Tapdi Oksijen Ozelglik ve Egitim Hizlmetlerinayi Ticaret AS ranks #247 out of 628 companies in the Healthcare Providers & Services industry, placing it in the top 39.3%.
Is Tapdi Oksijen Ozelglik ve Egitim Hizlmetlerinayi Ticaret AS's ROE % too high?
Tapdi Oksijen Ozelglik ve Egitim Hizlmetlerinayi Ticaret AS's current ROE % of 3.45% is 85% below median its 10-year median of 22.54. Over the past 10 years, this metric has ranged from a low of 9.05 to a high of 37.88. The Healthcare Providers & Services industry median ROE % is 5.72. Tapdi Oksijen Ozelglik ve Egitim Hizlmetlerinayi Ticaret AS's value of 3.45% is 39.7% below this industry median. Based on the distribution chart, Tapdi Oksijen Ozelglik ve Egitim Hizlmetlerinayi Ticaret AS ranks #247 out of 628 companies in the Healthcare Providers & Services industry, which is above the industry midpoint. Overall, Tapdi Oksijen Ozelglik ve Egitim Hizlmetlerinayi Ticaret AS has a GF Score™ of 93/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Tapdi Oksijen Ozelglik ve Egitim Hizlmetlerinayi Ticaret AS's ROE % compare to HCA and THC?
According to the Healthcare Providers & Services industry distribution chart, Tapdi Oksijen Ozelglik ve Egitim Hizlmetlerinayi Ticaret AS ranks #247 out of 628 companies for ROE %. This puts Tapdi Oksijen Ozelglik ve Egitim Hizlmetlerinayi Ticaret AS in the upper half of its industry. The industry median ROE % is 5.72. Tapdi Oksijen Ozelglik ve Egitim Hizlmetlerinayi Ticaret AS's value of 3.45% is 39.7% below this benchmark. Historically, Tapdi Oksijen Ozelglik ve Egitim Hizlmetlerinayi Ticaret AS's own ROE % has ranged from 9.05 to 37.88 over the past decade. While the company's 10-year median is 22.54 vs. the industry median of 5.72, Tapdi Oksijen Ozelglik ve Egitim Hizlmetlerinayi Ticaret AS has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good ROE % for a Healthcare Providers & Services company?
The median ROE % among Healthcare Providers & Services companies is 5.72, based on 628 companies in the industry. Companies in the top quartile (top 25%) have a ROE % significantly above this median, while those in the bottom quartile fall well below. However, ROE % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Tapdi Oksijen Ozelglik ve Egitim Hizlmetlerinayi Ticaret AS's current ROE % of 3.45% is 39.7% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high ROE % mean?
A high ROE % can signal that a stock is expensive relative to its fundamentals. Return on equity is the ratio of current-period net income to average two-period total equity. View historical data on Tapdi Oksijen Ozelglik ve Egitim Hizlmetlerinayi Ticaret AS and its competitors. For the Healthcare Providers & Services industry, the median ROE % is 5.72 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Tapdi Oksijen Ozelglik ve Egitim Hizlmetlerinayi Ticaret AS's current ROE % is 3.45%, which is 85% below median its own 10-year median of 22.54. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Tapdi Oksijen Ozelglik ve Egitim Hizlmetlerinayi Ticaret AS stock overvalued right now?
Based on GuruFocus' analysis, Tapdi Oksijen Ozelglik ve Egitim Hizlmetlerinayi Ticaret AS (IST:TNZTP) is currently considered Modestly Undervalued. The stock's GF Value™ is ₺29.23, compared to a current price of ₺26.06 — trading 10.8% below its estimated fair value. The current ROE % is 3.45%, which is 85% below median its 10-year median of 22.54 and 39.7% below the Healthcare Providers & Services industry median of 5.72. Tapdi Oksijen Ozelglik ve Egitim Hizlmetlerinayi Ticaret AS's overall GF Score™ is 93/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is ROE % calculated?
ROE % is calculated from a company's financial statements. For Tapdi Oksijen Ozelglik ve Egitim Hizlmetlerinayi Ticaret AS (IST:TNZTP), the current ROE % is 3.45% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Tapdi Oksijen Ozelglik ve Egitim Hizlmetlerinayi Ticaret AS (IST:TNZTP) Overvalued in 2026?

Based on GuruFocus' analysis, Tapdi Oksijen Ozelglik ve Egitim Hizlmetlerinayi Ticaret AS stock appears to be undervalued. The current stock price of ₺26.06 is trading 10.8% below its estimated GF Value™ of ₺29.23. GuruFocus considers Tapdi Oksijen Ozelglik ve Egitim Hizlmetlerinayi Ticaret AS to be Modestly Undervalued.

Key valuation signals for IST:TNZTP:

  • ROE %: 3.45% (85% below median its 10-year median of 22.54)
  • GF Value™: ₺29.23 vs. price of ₺26.06 (10.8% below fair value)
  • GF Score™: 93/100 with 2 warning signs
  • Industry Position: 39.7% below the Healthcare Providers & Services median (#247 of 628)

No single metric tells the full story. See the IST:TNZTP stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Tapdi Oksijen Ozelglik ve Egitim Hizlmetlerinayi Ticaret AS Business Description

Address No. 2 Kosu Yolu Caddesi, 506 Sokak Sirinyer Buca, Izmir, TUR
Tapdi Oksijen Ozel Saglik ve Egitim Hizlmetleri Sanayi Ticaret AS operates in the general medical and surgical hospitals sector. The company provides service in ?zmir with a medical center and two full fledged hospitals.
93GF Score

Get the complete analysis for IST:TNZTP

ROE % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₺26.06
Price
₺29.23
GF Value